Prohost Biotech - Exclusive Biotech Research - A Comprehensive Resource for Biotech News

AstraZeneca Saphnelo Approved in Japan for Adult Patients with SLE

September 28, 2021 0

AstraZeneca Saphnelo Approved by Japanese Ministry of Health, Labor and Welfare Developed by AstraZeneca (AZN), Saphnelo …

The Time Has Come to Present Mirum Pharmaceuticals Inc

September 27, 2021 0

Mirum Pharmaceuticals Inc Mirum Pharmaceuticals Inc (MIRM) is a clinical-stage biopharmaceutical company focused on the development …

The World Health Organization Recommends Regeneron Pharmaceuticals Antibody Cocktail for COVID-19

September 24, 2021 0

Regeneron Welcomes the World Health Organization's Recommendation for Use of REGEN- COVTM to Treat COVID-19 The …

Can Excision BioTherapeutics Inc Cure HIV?!

September 24, 2021 0

Excision BioTherapeutics, Inc. IND Application for EBT-101 for HIV Accepted by the US FDA Excision BioTherapeutics, …

Encouraging News from Cassava Sciences

September 22, 2021 0

Cassava Sciences Announces Top-Line Clinical Data for Simulfilam Cassava Sciences Press Release Today Cassava Sciences (SAVA) …

Seagen Inc and Genmab Announce FDA Accelerated Approval for TIVDAK™ for Cervical Cancer

September 21, 2021 0

Seagen and Genmab Granted FDA Accelerated Approval for TIVDAK™ The U.S. FDA granted accelerated approval to …

Comprehensive Prohost Letter Issues

September 19, 2021 0

The Comprehensive Prohost Letter Issues The Comprehensive Prohost Letter Issues will constitute a chain of 7 …

Gilead Sciences: New Data Demonstrate Trodelvy Survival Benefit in Metastatic TNBC. See Also: Galapagos NV News

September 17, 2021 0

Gilead Sciences New Data from Trodelvy® Study Gilead Sciences (GILD) has recently announced new data from …

The U.S. FDA Accepted Intellia Therapeutics IND Application of NTLA-5001 for Acute Myeloid Leukemia

September 16, 2021 0

Intellia Therapeutics IND Application of NTLA-5001 for AML is Accepted by the US FDA NTLA-5001 is …

Why Jounce Therapeutics Stock is Outperforming Today

September 14, 2021 0

Jounce Therapeutics Jounce Therapeutics (JNCE) is a clinical-stage immunotherapy company developing therapies enabling the immune system …

Regenxbio and AbbVie: A Good Reason for RGNX to Soar Today

September 13, 2021 0

Regenxbio and AbbVie in the NEWS Regenxbio (RGNX) stock soared today. The Company, along with AbbVie …

Why IVERIC bio Stock Rallied Today

September 10, 2021 0

IVERIC bio Stock Rally IVERIC bio (ISEE) stock rallied in early, premarket trading today as Stifel …

Gain Therapeutics: A Biotech with Promising Treatments for Neurodegenerative Diseases and a Note from Prohost Biotech

September 8, 2021 0

Gain Therapeutics Inc in the News Gain Therapeutics, Inc. (GANX) announced today topline data from its …

Interesting, Good News for Impel NeuroPharma and Migraine Sufferers

September 3, 2021 0

Impel NeuroPharma FDA Approval for TRUDHESA The U.S. Food and Drug Administration (FDA) approved Impel NeuroPharma …

Can-Fite Biopharma Has Encouraging News but Will It Enthuse Investors?

September 2, 2021 0

Can-Fite Biopharma Good News We learned, from Petach Tikva, Israel, that Can-Fite Biopharma (CANF) – a …

Positive News for TCR2 Therapeutics – The U.S. FDA Granted Orphan Drug Designation to Gavo-Cel for Cholangiocarcinoma

September 2, 2021 0

TCR2 Therapeutics TCR2 Therapeutics (TCRR) is a clinical-stage cell therapy company developing a pipeline of novel T …

BioMarin Pharmaceutical Inc Product VOXZOGO® is the First to Prevent Dwarfism in Europe

August 31, 2021 0

The most important news in biological sciences is the high degree of success the biological revolution …

Cassava Statement Regarding Plasma p-tau Analysis from a Previously Disclosed Phase 2b Study in Alzheimer’s Patients

August 27, 2021 0

Cassava Sciences Released a Statement Cassava Sciences, Inc. (SAVA) – a biotechnology company focused on Alzheimer’s …

Agenus Good News: Balstilimab Monotherapy Data Published in Gynecologic Oncology